期刊
MARINE DRUGS
卷 21, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/md21040229
关键词
self-assembly; conotoxin; analgesia; myristoylation; micelles
Chronic pain is a widespread health problem. Peptide drugs that block N-type Ca2+ channels, like omega-conotoxin MVIIA, have been used to alleviate chronic pain. However, the limited therapeutic window, severe side effects, and instability of MVIIA restrict its use. This study modified MVIIA to make it self-assemble into micelles, which prolonged the analgesic effect and reduced side effects in mice.
Chronic pain is one of the most prevalent health problems worldwide. An alternative to suppress or alleviate chronic pain is the use of peptide drugs that block N-type Ca2+ channels (Ca(v)2.2), such as omega-conotoxin MVIIA. Nevertheless, the narrow therapeutic window, severe neurological side effects and low stability associated with peptide MVIIA have restricted its widespread use. Fortunately, self-assembly endows the peptide with high stability and multiple functions, which can effectively control its release to prolong its duration of action. Inspired by this, MVIIA was modified with appropriate fatty acid chains to render it amphiphilic and easier to self-assemble. In this paper, an N-terminal myristoylated MVIIA (Myr-MVIIA, medium carbon chain length) was designed and prepared to undergo self-assembly. The present results indicated that Myr-MVIIA can self-assemble into micelles. Self-assembled micelles formed by Myr-MVIIA at higher concentrations than MVIIA can prolong the duration of the analgesic effect and significantly reduce or even eliminate the side effects of tremor and coordinated motor dysfunction in mice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据